Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaela Cipriani

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 5, 2010
Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced deathClotilde Lauro, Raffaela Cipriani, Myriam Catalano, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 11, 2011
CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodentsRaffaela Cipriani, Pia Villa, Giuseppina Chece, et al.
International Journal of Molecular Sciences|May 11, 2024
Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa PlatformsFarida Dakterzada, Raffaela Cipriani, Ricard López-Ortega, et al.
International Journal of Molecular Sciences|August 26, 2022
New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer's DiseaseMaría Almudena Coto-Vilcapoma, Juan Castilla-Silgado, Benjamín Fernández-García, et al.
Neuropharmacology|September 2, 2018
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitisAndrea Manterola, Ana Bernal-Chico, Raffaela Cipriani, et al.
Scientific Reports|August 27, 2025
Stepwise approach to alzheimer's disease diagnosis in primary care using cognitive screening, risk factors, neuroimaging and plasma biomarkersMiren Altuna, Maite García-Sebastián, Raffaela Cipriani, et al.
Biochemical Pharmacology|August 4, 2018
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelinationAndrea Manterola, Ana Bernal-Chico, Raffaela Cipriani, et al.
Parkinsonism & Related Disorders|February 12, 2022
Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriersAne Murueta-Goyena, Raffaela Cipriani, Mar Carmona-Abellán, et al.
Cell Death & Disease|October 16, 2020
Sorcin is an early marker of neurodegeneration, Ca<sup>2+</sup> dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseasesIlaria Genovese, Flavia Giamogante, Lucia Barazzuol, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 5, 2010
Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced deathClotilde Lauro, Raffaela Cipriani, Myriam Catalano, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 11, 2011
CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodentsRaffaela Cipriani, Pia Villa, Giuseppina Chece, et al.
International Journal of Molecular Sciences|May 11, 2024
Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa PlatformsFarida Dakterzada, Raffaela Cipriani, Ricard López-Ortega, et al.
International Journal of Molecular Sciences|August 26, 2022
New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer's DiseaseMaría Almudena Coto-Vilcapoma, Juan Castilla-Silgado, Benjamín Fernández-García, et al.
Neuropharmacology|September 2, 2018
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitisAndrea Manterola, Ana Bernal-Chico, Raffaela Cipriani, et al.
Scientific Reports|August 27, 2025
Stepwise approach to alzheimer's disease diagnosis in primary care using cognitive screening, risk factors, neuroimaging and plasma biomarkersMiren Altuna, Maite García-Sebastián, Raffaela Cipriani, et al.
Biochemical Pharmacology|August 4, 2018
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelinationAndrea Manterola, Ana Bernal-Chico, Raffaela Cipriani, et al.
Parkinsonism & Related Disorders|February 12, 2022
Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriersAne Murueta-Goyena, Raffaela Cipriani, Mar Carmona-Abellán, et al.
Cell Death & Disease|October 16, 2020
Sorcin is an early marker of neurodegeneration, Ca<sup>2+</sup> dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseasesIlaria Genovese, Flavia Giamogante, Lucia Barazzuol, et al.
Pageof 2